The Financial Impact on Reimbursement of Moderately Hypofractionated Postoperative Radiation Therapy for Breast Cancer: An International Consortium Report

How public health services pay for radiotherapy in Europe: an ESTRO–HERO analysis of reimbursement

(2020) Yolande Lievens et al.   LANCET ONCOLOGY

International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic

(2020) C.E. Coles et al.   CLINICAL ONCOLOGY

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

(2020) Adrian Murray Brunt et al.   LANCET

Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic

(2020) Giuseppe Curigliano et al.   BREAST

The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review

(2020) Gustavo Nader Marta et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

National costs and resource requirements of external beam radiotherapy: A time-driven activity-based costing model from the ESTRO-HERO project

(2019) Noemie Defourny et al.   RADIOTHERAPY AND ONCOLOGY

Alternative payment and care-delivery models in oncology: A systematic review

(2018) Emeline M. Aviki et al.   CANCER

Expanding Access to Radiation Therapy: An Update on Brazil's Current Challenges and Opportunities

(2018) Fabio Y. Moraes et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Nation-Scale Adoption of Shorter Breast Radiation Therapy Schedules Can Increase Survival in Resource Constrained Economies: Results From a Markov Chain Analysis

(2017) Atif J. Khan et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Cost evaluation to optimise radiation therapy implementation in different income settings: A time-driven activity-based analysis

(2017) Jacob Van Dyk et al.   RADIOTHERAPY AND ONCOLOGY

Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis

(2016) Noémie Defourny et al.   RADIOTHERAPY AND ONCOLOGY

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

(2016) A. Murray Brunt et al.   RADIOTHERAPY AND ONCOLOGY

Radiation Oncology Practice: Adjusting to a New Reimbursement Model

(2016) Andre Konski et al.   Journal of Oncology Practice

The Theory of Value-Based Payment Incentives and Their Application to Health Care

(2015) Douglas A. Conrad   HEALTH SERVICES RESEARCH

Hypofractionated radiotherapy in carcinoma breast: What we have achieved?

(2015) Tapesh Bhattacharyya et al.   Journal of Cancer Research and Therapeutics

Use of hypofractionated post-mastectomy radiotherapy reduces health costs by over $2000 per patient: An Australian perspective

(2015) Joshua W Mortimer et al.   Journal of Medical Imaging and Radiation Oncology

Expanding global access to radiotherapy

(2015) Rifat Atun et al.   LANCET ONCOLOGY

Uptake and Costs of Hypofractionated vs Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008–2013

(2014) Justin E. Bekelman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

(2014) EBCTCG (Early Breast Cancer Trialists' Collaborative Group)   LANCET

Economic burden of cancer across the European Union: a population-based cost analysis

(2013) Ramon Luengo-Fernandez et al.   LANCET ONCOLOGY

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials

(2011)   LANCET

Hypofractionated breast radiotherapy: Financial and economic consequences

(2010) Yolande Lievens   BREAST

Hypofractionated Whole-Breast Radiotherapy: Impact on Departmental Waiting Times and Cost

(2010) P Dwyer et al.   Journal of Medical Imaging and Radiation Oncology

What Is Value in Health Care?

(2010) Michael E. Porter   NEW ENGLAND JOURNAL OF MEDICINE

Time and motion study of radiotherapy delivery: Economic burden of increased quality assurance and IMRT

(2009) Evelyn Van de Werf et al.   RADIOTHERAPY AND ONCOLOGY

The cost of radiation therapy

(2008) Nicolas Paul Ploquin et al.   RADIOTHERAPY AND ONCOLOGY